JP2025514751A5 - - Google Patents
Info
- Publication number
- JP2025514751A5 JP2025514751A5 JP2024561779A JP2024561779A JP2025514751A5 JP 2025514751 A5 JP2025514751 A5 JP 2025514751A5 JP 2024561779 A JP2024561779 A JP 2024561779A JP 2024561779 A JP2024561779 A JP 2024561779A JP 2025514751 A5 JP2025514751 A5 JP 2025514751A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263333076P | 2022-04-20 | 2022-04-20 | |
| US63/333,076 | 2022-04-20 | ||
| US202263369656P | 2022-07-27 | 2022-07-27 | |
| US63/369,656 | 2022-07-27 | ||
| US202263376499P | 2022-09-21 | 2022-09-21 | |
| US202263376531P | 2022-09-21 | 2022-09-21 | |
| US63/376,499 | 2022-09-21 | ||
| US63/376,531 | 2022-09-21 | ||
| US202263384600P | 2022-11-21 | 2022-11-21 | |
| US63/384,600 | 2022-11-21 | ||
| PCT/US2023/065998 WO2023205724A2 (en) | 2022-04-20 | 2023-04-20 | Cells comprising a suppressor of gene expression and/or a synthetic pathway activator and/or an inducible payload |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025514751A JP2025514751A (ja) | 2025-05-09 |
| JPWO2023205724A5 JPWO2023205724A5 (https=) | 2026-04-21 |
| JP2025514751A5 true JP2025514751A5 (https=) | 2026-04-21 |
Family
ID=88420722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561779A Pending JP2025514751A (ja) | 2022-04-20 | 2023-04-20 | 遺伝子発現のサプレッサー及び／または合成経路活性化因子及び／または誘導性ペイロードを含む細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250049854A1 (https=) |
| EP (1) | EP4496806A2 (https=) |
| JP (1) | JP2025514751A (https=) |
| CN (1) | CN119156398A (https=) |
| AU (1) | AU2023256671A1 (https=) |
| CA (1) | CA3248111A1 (https=) |
| MX (1) | MX2024012971A (https=) |
| WO (1) | WO2023205724A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20252678A1 (es) * | 2023-03-13 | 2025-11-24 | Arsenal Biosciences Inc | Activadores de vias sinteticas |
| AU2024340744A1 (en) * | 2023-09-14 | 2026-04-16 | Outpace Bio, Inc. | Anti-mesothelin chimeric antigen receptors and methods of use |
| WO2025085846A1 (en) * | 2023-10-20 | 2025-04-24 | A2 Biotherapeutics, Inc. | Engineered interleukins and uses thereof |
| CN121449751A (zh) * | 2024-07-31 | 2026-02-03 | 浙江瑞加美生物科技有限公司 | 一种功能增强的通用型双靶点BCMA/CD19-mbIL15-CAR-DNT细胞的构建、制备与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3095757A1 (en) * | 2018-04-06 | 2019-10-10 | The Regents Of The University Of California | Methods of treating glioblastomas |
| WO2021096783A1 (en) * | 2019-11-07 | 2021-05-20 | The Regents Of The University Of California | Use of mog for priming a treatment for glioblastoma |
| AU2021334366A1 (en) * | 2020-08-28 | 2023-05-11 | Arsenal Biosciences, Inc. | Engineered immune cells with priming receptors |
| AU2022366987A1 (en) * | 2021-10-14 | 2024-05-16 | Arsenal Biosciences, Inc. | Immune cells having co-expressed shrnas and logic gate systems |
-
2023
- 2023-04-20 EP EP23792773.6A patent/EP4496806A2/en active Pending
- 2023-04-20 CN CN202380038696.4A patent/CN119156398A/zh active Pending
- 2023-04-20 JP JP2024561779A patent/JP2025514751A/ja active Pending
- 2023-04-20 WO PCT/US2023/065998 patent/WO2023205724A2/en not_active Ceased
- 2023-04-20 CA CA3248111A patent/CA3248111A1/en active Pending
- 2023-04-20 AU AU2023256671A patent/AU2023256671A1/en active Pending
-
2024
- 2024-10-17 US US18/919,328 patent/US20250049854A1/en active Pending
- 2024-10-21 MX MX2024012971A patent/MX2024012971A/es unknown